Vaccine Design and Testing – Products

PEPotec Immuno Peptide Libraries for epitope mapping of B- and T-cells, vaccine development and screening of peptide vaccines.

High immune response rate of 84% in heavily pre-treated NSCLC patients.

ProPresent™ is a new assay service for the direct identification of the portions of a protein (antigen) that are made visible to T cells by the immune system.

DPX-Survivac will be tested in patients with ovarian cancer.

BiondVax’s Multimeric-001 Universal Influenza Vaccine successfully meets primary and secondary endpoints with strong safety and immunogenicity data in 200 participants.

BiondVax’s Multimeric-001 Universal Influenza Vaccine successfully meets primary and secondary endpoints with strong safety and immunogenicity data in 200 participants.

PharmaNet collaborate with CITN to help identify trials with immunotherapy agents prioritized by the CITN as having high potential for cancer therapy.

Researchers report the use of high-throughput sequencing technology to identify a novel hepatitis C virus in domestic dogs.

Dipeptide and tripeptide libraries can be systematically constructed to contain almost all possible combinations of the 20 common amino acids.